Printer Friendly

CASCADE MEDICAL NAMES DIRECTOR OF INTERNATIONAL SALES; DOMAN, FORMERLY WITH AMERICAN STERILIZER COMPANY

 MINNEAPOLIS, Jan. 29 /PRNewswire/ -- Cascade Medical, Inc., Eden Prairie, Minn., has appointed Christopher Doman to the position of director of international sales. He will have responsibility for all sales of CheckMate(TM) products outside of the United States.
 "We're very happy to add Chris' expertise in international marketing to the company," said Richard E. Jones, Ph.D., president and CEO of Cascade Medical. "His skills will play a crucial role in achieving worldwide distribution for our products."
 Most recently, Doman was director of worldwide sales and marketing for Analytical Biochemistry Laboratories, Columbia, Mo. Prior to this Doman spent 12 years in the surgical and health care markets in a series of positions at the American Sterilizer Co. (AMSCO International), Erie, Penn., including marketing manager for sterilization products; director of international marketing; international manager - strategic planning and acquisitions; and international area sales manager - South America.
 Doman has a master's degree in international marketing from the American Graduate School of International Management ("Thunderbird"), Glendale, Ariz., and a bachelor's degree from the College of St. Thomas, St. Paul, Minn.
 The addition of Doman further rounds out Cascade's quickly growing sales and marketing team headed by Ronald Jackson, formerly of Gillette and Totes.
 In the fall of 1992, Cascade Medical signed agreements for distribution of its CheckMate system in Korea and Singapore, further expanding its distribution network in the United States, Europe, the Middle East and East Asia. Cascade also recently acquired exclusive worldwide rights to market a next-generation, noninvasive blood glucose monitor under development by Boston Advanced Technologies, Newton, Mass.
 Cascade Medical, founded in 1989, is a privately held manufacturer of diabetes products. Cascade Medical developed, manufactures and holds the patents for its CheckMate blood glucose home monitoring system and disposable test strips, previously marketed under the name Answer(R) Blood Glucose Monitoring system. Cascade has achieved nationwide distribution of its CheckMate system and is presently establishing distribution in several key international markets.
 -0- 1/29/93
 /CONTACT: Perry Ketchum of Ketchum & Metz, Inc., 612-349-2727, for Cascade Medical/


CO: Cascade Medical, Inc. ST: Minnesota IN: MTC SU: PER

AL -- MN005 -- 0843 01/29/93 14:39 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 29, 1993
Words:354
Previous Article:CYGNUS REPORTS 1992 RESULTS 'ENTERING THE MARKET'
Next Article:HOME PORT BANCORP, INC. REPORTS FOURTH QUARTER RESULTS
Topics:


Related Articles
ALCO INTERNATIONAL GROUP ANNOUNCES APPOINTMENT OF TWO DIRECTORS
CASCADE MEDICAL NAMES SALES & MARKETING VICE PRESIDENT
CASCADE MEDICAL NAMES BRUNSTING SENIOR OPTICAL ENGINEER
CASCADE MEDICAL NAMES DIXON TO BOARD OF DIRECTORS
CASCADE MEDICAL NAMES CHIEF FINANCIAL OFFICER; MCFADDEN HELD SERIES OF POSITIONS AT CRAY RESEARCH
BOWMAR ANNOUNCES PRELIMINARY ACQUISITION AGREEMENT
CYCLOPSS MEDICAL FILES FDA APPLICATION FOR MARKETING CLEARANCE FOR OZONE STERILIZER
ETC RECEIVES $550,000 IN STERILIZER CONTRACTS
ST. JUDE MEDICAL ANNOUNCES INTERNATIONAL MANAGEMENT CHANGES
TSO3 obtains FDA authorization to commercialize its Ozone Sterilizer and chemical indicator; Stock Symbol: TSX - TOS, TOS.WT.B Outstanding Shares:...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters